The supply on the Hepatitis C drug to Vertex by Shasun Chemicals is set to take off earlier than anticipated. "Commercial supplies have already started and this year we are preparing for the launch," says Vimal Kumar, Managing Director of Shasun Chemicals, in an exclusive interview with CNBC-TV18.
first published: Jan 5, 2011 01:33 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
Live: Will US-Venezuela tensions derail Nifty's upmove? | Oil stocks in focus | Opening Bell
New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live
Nifty Trades in a Narrow 100-Point Range on 2025’s Final F&O Expiry | Closing Bell Live
